Trifarma

Trifarma is an established Italian pharmaceutical company that specializes in the development and manufacturing of Active Pharmaceutical Ingredients (APIs) for the global market. Founded in 1963 and headquartered in Rozzano, Italy, the company operates two high-capacity manufacturing sites that are fully compliant with cGMP standards and inspected by major regulatory bodies including the US FDA and Italy's AIFA. Trifarma's product portfolio focuses on small molecule APIs across diverse therapeutic areas such as the central nervous system, cardiovascular health, and gastroenterology. In 2019, the company was acquired by Alchem International, a move that integrated Trifarma into a larger global supply chain and expanded its technical resources. The company provides both generic APIs and custom synthesis services, supporting pharmaceutical clients from development through to commercial-scale production.